← Back to Search

Procedure

Endoscopic Sleeve Gastroplasty for Non-alcoholic Fatty Liver Disease

N/A
Recruiting
Led By Shailendra Singh, MD
Research Sponsored by West Virginia University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months post esg
Awards & highlights
No Placebo-Only Group

Summary

Endoscopic weight loss procedures, also termed endoscopic sleeve gastroplasty (ESG), has been proposed as a non-surgical procedure for managing obesity and offers a standard weight loss approach. Realizing there is a knowledge gap in applying ESG to morbidly obese patients with NAFLD, the investigators propose studying the efficacy of weight control and functional outcomes of ESG. This prospective pilot study is aimed to study the safety profiles, quality of life, and changes and improvements in the anthropometric, metabolic, and biochemical changes in these patients.

Eligible Conditions
  • Non-alcoholic Fatty Liver Disease

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months post esg
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months post esg for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in Controlled Attenuation Parameter of Steatosis
Change in Liver Stiffness Measurement of Fibrosis
Secondary study objectives
Absolute Body Weight Loss Changes
Anthropometric Evaluation
BMI Changes
+2 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Endoscopic Sleeve GastroplastyExperimental Treatment1 Intervention
endoscopic suturing of the stomach
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Endoscopic Sleeve Gastroplasty
2017
Completed Phase 2
~110

Find a Location

Who is running the clinical trial?

West Virginia UniversityLead Sponsor
183 Previous Clinical Trials
63,843 Total Patients Enrolled
Shailendra Singh, MDPrincipal InvestigatorWest Virginia University
1 Previous Clinical Trials
12 Total Patients Enrolled
~9 spots leftby Oct 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top